GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Palatin Technologies, Inc. (PTN) [hlAlert]

Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company engaged in the development of peptide, peptide mimetic and small molecule compounds with a focus on melanocortin and natriuretic peptide receptor systems. The Company has a diverse pipeline of development programs, including development of proposed
products for treatment of heart failure (HF), sexual dysfunction, obesity, diabetes and metabolic syndrome. As of June 30, 2009, Palatin?s products under development included bremelanotide, a peptide melanocortin receptor, for treatment of sexual dysfunction, targeting female sexual dysfunction (FSD) and erectile dysfunction (ED) in patients non-responsive to current therapies, PL-6983, a peptide melanocortin receptor agonists, for treatment of sexual dysfunction; PL-3994, a peptide mimetic natriuretic peptide receptor A (NPRA) agonist, for treatment of HF and melanocortin receptor-based compounds for treatment of obesity and related metabolic syndrome.
.
( Total: 2 Current Stock Recommendations )
Palatin Technologies, Inc.   (2)
Buy 100%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
5/23/2012  
Buy
  
6/21/2013  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy